These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 18556411)

  • 1. CXCR4 pos circulating progenitor cells coexpressing monocytic and endothelial markers correlating with fibrotic clinical features are present in the peripheral blood of patients affected by systemic sclerosis.
    Campioni D; Lo Monaco A; Lanza F; Moretti S; Ferrari L; Fotinidi M; La Corte R; Cuneo A; Trotta F
    Haematologica; 2008 Aug; 93(8):1233-7. PubMed ID: 18556411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impairment of endothelial cell differentiation from bone marrow-derived mesenchymal stem cells: new insight into the pathogenesis of systemic sclerosis.
    Cipriani P; Guiducci S; Miniati I; Cinelli M; Urbani S; Marrelli A; Dolo V; Pavan A; Saccardi R; Tyndall A; Giacomelli R; Cerinic MM
    Arthritis Rheum; 2007 Jun; 56(6):1994-2004. PubMed ID: 17530639
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Circulating endothelial cells as a marker of ongoing vascular disease in systemic sclerosis.
    Del Papa N; Colombo G; Fracchiolla N; Moronetti LM; Ingegnoli F; Maglione W; Comina DP; Vitali C; Fantini F; Cortelezzi A
    Arthritis Rheum; 2004 Apr; 50(4):1296-304. PubMed ID: 15077314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Primary hyperparathyroidism is associated with increased circulating bone marrow-derived progenitor cells.
    Brunner S; Theiss HD; Murr A; Negele T; Franz WM
    Am J Physiol Endocrinol Metab; 2007 Dec; 293(6):E1670-5. PubMed ID: 17911347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Two types of circulating endothelial progenitor cells in patients receiving long term therapy by HMG-CoA reductase inhibitors.
    Deschaseaux F; Selmani Z; Falcoz PE; Mersin N; Meneveau N; Penfornis A; Kleinclauss C; Chocron S; Etievent JP; Tiberghien P; Kantelip JP; Davani S
    Eur J Pharmacol; 2007 May; 562(1-2):111-8. PubMed ID: 17320859
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relationship between plasma microparticles and disease manifestations in patients with systemic sclerosis.
    Guiducci S; Distler JH; Jüngel A; Huscher D; Huber LC; Michel BA; Gay RE; Pisetsky DS; Gay S; Matucci-Cerinic M; Distler O
    Arthritis Rheum; 2008 Sep; 58(9):2845-53. PubMed ID: 18759303
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased serum levels of fractalkine and mobilisation of CD34
    Benyamine A; Magalon J; Cointe S; Lacroix R; Arnaud L; Bardin N; Rossi P; Francès Y; Bernard-Guervilly F; Kaplanski G; Harlé JR; Weiller PJ; Berbis P; Braunstein D; Jouve E; Lesavre N; Couranjou F; Dignat-George F; Sabatier F; Paul P; Granel B
    Arthritis Res Ther; 2017 Mar; 19(1):60. PubMed ID: 28320472
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Simvastatin reduces endothelial activation and damage but is partially ineffective in inducing endothelial repair in systemic sclerosis.
    Del Papa N; Cortiana M; Vitali C; Silvestris I; Maglione W; Comina DP; Lucchi T; Cortelezzi A
    J Rheumatol; 2008 Jul; 35(7):1323-8. PubMed ID: 18528965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Circulating stem cell vary with NYHA stage in heart failure patients.
    Fortini C; Toffoletto B; Fucili A; Puppato E; Olivares A; Beltrami AP; Fiorelli V; Bergamin N; Cesselli D; Morelli C; Francolini G; Ferrari R; Beltrami CA
    J Cell Mol Med; 2011 Aug; 15(8):1726-36. PubMed ID: 21029373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of cellular immunity in systemic sclerosis pathogenesis: update on CD4+T cells population studies.
    Beşliu AN; Bănică LM; Lonescu R; Predeţeanu D; Stăvaru C; Marica CM; Chiţonu C; Pistol G; Stefănescu M; Matache C
    Roum Arch Microbiol Immunol; 2009; 68(1):5-13. PubMed ID: 19507621
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD34+ hemopoietic precursor and stem cells traffic in peripheral blood of celiac patients is significantly increased but not directly related to epithelial damage severity.
    Mastrandrea F; Semeraro FP; Coradduzza G; Manelli M; Scarcia G; Pezzuto F; Serio G
    Eur Ann Allergy Clin Immunol; 2008 Nov; 40(3):90-103. PubMed ID: 19334373
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of stromal-cell-derived factor-1 on circulating platelets is increased in patients with acute coronary syndrome and correlates with the number of CD34+ progenitor cells.
    Stellos K; Bigalke B; Langer H; Geisler T; Schad A; Kögel A; Pfaff F; Stakos D; Seizer P; Müller I; Htun P; Lindemann S; Gawaz M
    Eur Heart J; 2009 Mar; 30(5):584-93. PubMed ID: 19109356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenic T cell expansion correlates with severity of peripheral vascular damage in systemic sclerosis.
    Manetti M; Pratesi S; Romano E; Bellando-Randone S; Rosa I; Guiducci S; Fioretto BS; Ibba-Manneschi L; Maggi E; Matucci-Cerinic M
    PLoS One; 2017; 12(8):e0183102. PubMed ID: 28797111
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Endothelial and myogenic differentiation of hematopoietic progenitor cells in inflammatory myopathies.
    Hollemann D; Budka H; Löscher WN; Yanagida G; Fischer MB; Wanschitz JV
    J Neuropathol Exp Neurol; 2008 Jul; 67(7):711-9. PubMed ID: 18596542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Update on the pathogenesis of Scleroderma: focus on circulating progenitor cells.
    Brunasso AM; Massone C
    F1000Res; 2016; 5():. PubMed ID: 27158466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effector CD8+ T cells in systemic sclerosis patients produce abnormally high levels of interleukin-13 associated with increased skin fibrosis.
    Fuschiotti P; Medsger TA; Morel PA
    Arthritis Rheum; 2009 Apr; 60(4):1119-28. PubMed ID: 19333920
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma levels of FL and SDF-1 and expression of FLT-3 and CXCR4 on CD34+ cells assessed pre and post hematopoietic stem cell mobilization in patients with hematologic malignancies and in healthy donors.
    Cecyn KZ; Schimieguel DM; Kimura EY; Yamamoto M; Oliveira JS
    Transfus Apher Sci; 2009 Jun; 40(3):159-67. PubMed ID: 19380254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mechanisms of vascular damage in SSc--implications for vascular treatment strategies.
    Guiducci S; Distler O; Distler JH; Matucci-Cerinic M
    Rheumatology (Oxford); 2008 Oct; 47 Suppl 5():v18-20. PubMed ID: 18784130
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Angiogenesis in systemic sclerosis: impaired expression of vascular endothelial growth factor receptor 1 in endothelial progenitor-derived cells under hypoxic conditions.
    Avouac J; Wipff J; Goldman O; Ruiz B; Couraud PO; Chiocchia G; Kahan A; Boileau C; Uzan G; Allanore Y
    Arthritis Rheum; 2008 Nov; 58(11):3550-61. PubMed ID: 18975312
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of stem cell markers on mononuclear cells derived from heparinized cadaveric organ donors before and after disconnection from the respirator.
    Machaliński B; Paczkowska E; Hałasa M; Pabisiak K; Walczak M; Sieńko J; Kozik W; Ostrowski M; Syrenicz A; Sulikowski T; Machalińska A
    Transplant Proc; 2006; 38(1):16-9. PubMed ID: 16504653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.